Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study

Transplantation
Helio Tedesco-SilvaTRANSFORM Investigators

Abstract

The safety profiles of standard therapy versus everolimus with reduced-exposure calcineurin inhibitor (CNI) therapy using contemporary protocols in de novo kidney transplant recipients have not been compared in detail. TRANSFORM was a randomized, international trial in which de novo kidney transplant patients were randomized to everolimus with reduced-exposure CNI (N = 1014) or mycophenolic acid (MPA) with standard-exposure CNI (N = 1012), both with induction and corticosteroids. Within the safety population (everolimus 1014, MPA 1012), adverse events with a suspected relation to study drug occurred in 62.9% versus 59.2% of patients given everolimus or MPA, respectively (P = 0.085). Hyperlipidemia, interstitial lung disease, peripheral edema, proteinuria, stomatitis/mouth ulceration, thrombocytopenia, and wound healing complications were more frequent with everolimus, whereas diarrhea, nausea, vomiting, leukopenia, tremor, and insomnia were more frequent in the MPA group. The incidence of viral infections (17.2% versus 29.2%; P < 0.001), cytomegalovirus (CMV) infections (8.1% versus 20.1%; P < 0.001), CMV syndrome (13.6% versus 23.0%, P = 0.044), and BK virus (BKV) infections (4.3% versus 8.0%, P < 0.001) were less frequent wit...Continue Reading

References

Jul 25, 2007·Clinical Transplantation·Richard J KnightBarry D Kahan
Dec 21, 2007·The New England Journal of Medicine·Henrik EkbergUNKNOWN ELITE-Symphony Study
May 12, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·H Tedesco SilvaY S Kim
May 27, 2010·Transplant International : Official Journal of the European Society for Organ Transplantation·Jacques DantalUNKNOWN RAD A2420 Study Group
Nov 8, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S Bunnapradist, K Kalantar-Zadeh
Apr 17, 2012·Cell·Mathieu Laplante, David M Sabatini
Sep 8, 2012·Expert Opinion on Drug Safety·Hallvard HoldaasAnders Åsberg
Aug 3, 2013·Thrombosis Research·Marije C BaasFrederike J Bemelman
Sep 17, 2013·Transplantation Proceedings·P TodeschiniS Stefoni
Oct 5, 2013·Journal of the American Society of Nephrology : JASN·Brandon RennerJoshua M Thurman
Apr 2, 2014·Transplantation Reviews·Bruce KaplanJason R Wellen
Sep 18, 2014·Transplantation Reviews·Hallvard HoldaasFaouzi Saliba
May 20, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·H Tedesco-SilvaJ Medina-Pestana
Nov 18, 2015·Transplant International : Official Journal of the European Society for Organ Transplantation·J BelliereL Rostaing
Mar 25, 2016·World Journal of Transplantation·Alberto Baroja-MazoJosé A Pons
Oct 25, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Y QaziS Mulgaonkar
Jun 13, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Klemens BuddeUNKNOWN HERAKLES Study Group
May 13, 2018·Journal of the American Society of Nephrology : JASN·Julio PascualUNKNOWN TRANSFORM Investigators

❮ Previous
Next ❯

Citations

Jun 4, 2019·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Stefan P BergerUNKNOWN TRANSFORM investigators
Dec 17, 2019·The Cochrane Database of Systematic Reviews·Deirdre HahnAngela C Webster
Dec 5, 2019·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Thomas MühlbacherMartina Guthoff
Dec 14, 2019·Current Opinion in Organ Transplantation·Ondrej ViklickyPetra Hruba
Feb 6, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Yannick Le MeurBenoit Barrou
Feb 23, 2020·Expert Review of Anti-infective Therapy·Mario Fernández-RuizJosé María Aguado
Jun 14, 2020·Journal of Nephrology·Elisabetta BussalinoErnesto Paoletti
Dec 20, 2019·Expert Review of Anti-infective Therapy·Isabel Rodríguez-GoncerJosé María Aguado
Dec 7, 2020·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Rachel Hellemans, Daniel Abramowicz
Dec 18, 2020·Current Opinion in Organ Transplantation·Ondrej ViklickyPetra Hruba
Mar 8, 2020·Enfermedades infecciosas y microbiología clínica·Jose Tiago SilvaJosé María Aguado
Jun 17, 2020·Transplantation·Song C Ong, Robert S Gaston
Feb 13, 2021·European Journal of Clinical Investigation·Paul Spechtl, Rainer Oberbauer
Jun 28, 2020·Transplantation Proceedings·Ewa Nowacka-CieciuraMagdalena Durlik
Oct 31, 2020·Transplantation Proceedings·Valentine GierczakJohan Noble
May 8, 2021·Current Hypertension Reports·Christos ChatzikyrkouMario Schiffer
Jun 10, 2021·Arab Journal of Urology·Ahmed A ShokeirRashad Barsoum
Jun 20, 2021·Transplant International : Official Journal of the European Society for Organ Transplantation·Rachel HellemansUNKNOWN for ESOT Workstream 3 of the TLJ (Transplant Learning Journey) project
Jun 4, 2019·Current Opinion in Organ Transplantation·Camille N Kotton
Nov 3, 2021·Journal of the American Society of Nephrology : JASN·Hannah KaminskiJulie Déchanet-Merville

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.